Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

Aksu, Feyza; Caliskan, Mustafa; Keles, Nursen; Toprak, Aybala; Uzuncakmak, Tuğba; Kostek, Osman; Yilmaz, Yusuf; Demircioglu, Kenan; Cekin, Esad; Ozturk, Ibrahim; Karadag, Ayse

doi:10.5603/cj.a2017.0031

Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

Aksu F., Caliskan M., Keles N., Toprak A. E. , Uzuncakmak T. K. , Kostek O., ...More

CARDIOLOGY JOURNAL, vol.24, no.3, pp.276-283, 2017 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 24 Issue: 3
Publication Date: 2017
Doi Number: 10.5603/cj.a2017.0031
Title of Journal : CARDIOLOGY JOURNAL
Page Numbers: pp.276-283

Abstract

Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.